We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Comparison of Human and Mouse Interleukins Reveals Link

By LabMedica International staff writers
Posted on 05 Feb 2019
A study comparing the structure and function of human and mouse interleukins revealed a close link between protein folding and immune regulation.

Interleukins are small, secreted proteins that drive immune cell communication. More...
Understanding how cells produce interleukins is considered to be critical for decoding and modulating immune responses. An example of particular complexity and biological relevance is the interleukin 12 (IL-12) family. Four functionally distinct alpha-beta heterodimers are assembled from only five subunits to regulate immune cell function and development. In addition, some subunits act as independent signaling molecules. In particular, IL-27 is composed of two subunits, alpha and beta. In humans, these have to assemble to form bioactive IL-27, whereas in mice, IL-27alpha can be secreted alone, modulating immune reactions and reducing sepsis-related mortality.

Investigators at the Technical University of Munich (Germany) reported in the January 16, 2019, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America that differences in a single amino acid determined if IL-27alpha could be secreted autonomously, acting as a signaling molecule, or if it depended on hetero-dimerization for secretion.

By combining computer simulations with biochemical experiments, the investigators dissected the underlying structural determinants: a protein folding switch coupled to disulfide bond formation regulated chaperone-mediated retention versus secretion.

Using these insights the investigators changed folding and assembly control for this protein. This provided the basis for a more human-like IL-27 system in mice and established a secretion-competent human IL-27alpha that signaled on its own and could regulate immune cell function.

"The interleukins are the vocabulary with which immune cells communicate," explained Dr. Matthias Feige, professor of cellular protein biochemistry at the Technical University of Munich. "The cells form these messenger molecules according to a very specific blueprint of individual amino acids. Their arrangement determines, which three-dimensional structure an interleukin adopts and, consequently, which information it transmits. Our approach allowed us to rationally extend the language of immune cells by engineering a key signaling molecule. This provides us with an opportunity to modulate the reaction of immune cells in a targeted manner."

Related Links:
Technical University of Munich


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.